⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SLNO News
Soleno Therapeutics, Inc. Common Stock
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Hyperphagia Drug Launch Disruptions - Hagens Berman
prnewswire.com
SLNO
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – SLNO
globenewswire.com
SLNO
DEADLINE ALERT for BSX, EOSE, SLNO, and NKTR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
globenewswire.com
NKTR
EOSE
BSX
SLNO
Portnoy Law Firm Announces Class Action on Behalf of Soleno Therapeutics, Inc. Investors
globenewswire.com
SLNO
SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm
prnewswire.com
SLNO
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Soleno Therapeutics, Inc. (SLNO)
globenewswire.com
SLNO
SLNO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SLNO
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
accessnewswire.com
SLNO
Are SLNO, BLD, STEL Obtaining Fair Deals for their Shareholders?
prnewswire.com
STEL
BLD
SLNO
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Concealed Drug Risks: Levi & Korsinsky
globenewswire.com
SLNO